Zobrazeno 1 - 10
of 344
pro vyhledávání: '"Kristian Wachtell"'
Autor:
Edina Hadziselimovic, Anders M. Greve, Ahmad Sajadieh, Michael H. Olsen, Y. Antero Kesäniemi, Christoph A. Nienaber, Simon G. Ray, Anne B. Rossebø, Kristian Wachtell, Olav W. Nielsen
Publikováno v:
EClinicalMedicine, Vol 58, Iss , Pp 101875- (2023)
Summary: Background: High-sensitivity Troponin T (hsTnT), a biomarker of cardiomyocyte overload and injury, relates to aortic valve replacement (AVR) and mortality in severe aortic stenosis (AS). However, its prognostic value remains unknown in asymp
Externí odkaz:
https://doaj.org/article/8157356adc6a439589764fccbf797fbc
Autor:
Marcello Chinali, Gerard P. Aurigemma, Eva Gerdts, Kristian Wachtell, Peter M. Okin, Anujan Muthiah, Sverre E. Kjeldsen, Stevo Julius, Giovanni de Simone, Richard B. Devereux
Publikováno v:
Exploration of Medicine, Vol 3, Iss 2, Pp 160-172 (2022)
Aim: While it is commonly thought that left ventricular (LV) systolic function may insidiously deteriorate in hypertensive patients, few prospective data are available to support this notion. Methods: We evaluated 680 hypertensive patients (66 ± 7 y
Externí odkaz:
https://doaj.org/article/ea8b12ec3d1040af891a6ebd87db29f2
Autor:
Casper N. Bang, Anders M. Greve, Lars Køber, Anujan Muthiah, Sverre E. Kjeldsen, Stevo Julius, Kristian Wachtell, Richard B. Devereux, Peter M. Okin
Publikováno v:
Exploration of Medicine, Vol 3, Iss 2, Pp 139-148 (2022)
Aim: The present study investigated the appearance and severity of atrial fibrillation (AF) and heart failure (HF) in 8,702 hypertensive patients with left ventricular hypertrophy (LVH) receiving antihypertensive treatment in a prospective trial. Met
Externí odkaz:
https://doaj.org/article/494df5eb0be84c22aefc925084ebab2c
Autor:
Casper N. Bang, Zhibin Li, Ildri M. Stokke, Sverre E. Kjeldsen, Stevo Julius, Darcy A. Hille, Kristian Wachtell, Richard B. Devereux, Peter M. Okin
Publikováno v:
Exploration of Medicine, Vol 3, Iss 2, Pp 149-159 (2022)
Aim: Whether incident left bundle branch block (LBBB) is associated with increased cardiovascular (CV) morbidity and mortality in treated hypertensive patients with left ventricular hypertrophy (LVH) is unknown. Thus, the present study aimed to exami
Externí odkaz:
https://doaj.org/article/4299c038f5a845e8bff5ca7bac58d154
Autor:
Eran S. Zacks, Ildri M. Stokke, Kristian Wachtell, Darcy A. Hille, Aud Høieggen, Sverre E. Kjeldsen, Stevo Julius, Eva Gerdts, Peter M. Okin, Richard B. Devereux
Publikováno v:
Exploration of Medicine, Vol 3, Iss 2, Pp 128-138 (2022)
Aim: The Losartan Intervention For Endpoint reduction in hypertension (LIFE) study showed less new-onset atrial fibrillation (AF) in hypertensive patients receiving losartan- vs. atenolol-based treatment. Because losartan reduces serum uric acid (SUA
Externí odkaz:
https://doaj.org/article/1f7f2e6f0c3045f9afa145edb49c0133
Autor:
Peter M. Okin, Darcy A. Hille, Kristian Wachtell, Sverre E. Kjeldsen, Stevo Julius, Richard B. Devereux
Publikováno v:
Blood Pressure, Vol 29, Iss 5, Pp 319-326 (2020)
Purpose: Hypertensive patients are at increased risk of atrial fibrillation (AF). Although low baseline high density lipoprotein (HDL) cholesterol has been associated with a higher risk of AF, this has not been verified in recent population-based stu
Externí odkaz:
https://doaj.org/article/461a0c1121a94a68a18222318c12fc3e
Autor:
Anne C. K. Larstorp, Ildri M. Stokke, Sverre E. Kjeldsen, Michael Hecht Olsen, Peter M. Okin, Richard B. Devereux, Kristian Wachtell
Publikováno v:
Blood Pressure, Vol 28, Iss 5, Pp 317-326 (2019)
Aims: Atrial fibrillation (AF) is associated with increased cardiovascular risk and the incidence increases with age, hypertension and left ventricular hypertrophy (LVH). Reducing in-treatment systolic blood pressure (SBP) prevents new-onset AF but h
Externí odkaz:
https://doaj.org/article/5a7653ed93964fbc8e94d71a4cb3c38e
Autor:
Ildri M. Stokke, Zhi Bin Li, Silvana Cicala, Peter M. Okin, Sverre E. Kjeldsen, Richard B. Devereux, Kristian Wachtell
Publikováno v:
Blood Pressure, Vol 28, Iss 2, Pp 84-92 (2019)
Aims: We aimed to investigate whether left bundle branch block (LBBB) is related to new-onset left ventricle (LV) wall motion abnormalities during treatment in hypertensive patients with electrocardiographic (ECG) defined left ventricular hypertrophy
Externí odkaz:
https://doaj.org/article/e1c1c62d085e4614b780198c2fefc247
Autor:
Alexander Lilja-Cyron, Casper N. Bang, Eva Gerdts, Anne C. Larstorp, Sverre E. Kjeldsen, Stevo Julius, Peter M. Okin, Kristian Wachtell, Richard B. Devereux
Publikováno v:
Reviews in Cardiovascular Medicine, Vol 23, Iss 3, p 095 (2022)
Background: Available nomograms to predict aortic root (AoR) diameter for body surface area have limitations. The purpose of this study was to evaluate the use of a new multivariate predictive model to identify AoR dilatation in hypertensive patients
Externí odkaz:
https://doaj.org/article/1f2303c5de4f4c54a5ac3d38abbd2b30
Autor:
Costantino Mancusi, Eva Gerdts, Giovanni de Simone, Helga Midtbø, Mai Tone Lønnebakken, Kurt Boman, Kristian Wachtell, Björn Dahlöf, Richard B. Devereux
Publikováno v:
Blood Pressure, Vol 26, Iss 3, Pp 150-155 (2017)
We tested the prognostic impact of a marker of arterial stiffness, pulse pressure/stroke volume index (PP/SVi), in patients with hypertension and left ventricular (LV) hypertrophy. We used data from 866 patients randomized to losartan or atenolol-bas
Externí odkaz:
https://doaj.org/article/5a2bea31fa4e48c9a891e16abda06af3